Patients and cancer experts launch a joint vision for improving cancer outcomes in EuropeMyeloma, Patient evidence12 January 2017
Innovative Medicines Initiative (IMI) approves € 40 million project for better care of patients with haematologic malignanciesMyeloma9 January 2017
Addition of daratumumab to bortezomib and dexamethasone in patients with relapsed or refractory shows promising results in a phase III trialMyeloma13 October 2016
SURVEY: Reasonable agreements between pharmaceutical companies and patient advocatesMPE6 October 2016
EMA reconsiders and gives its positive opinion for the approval of ixazomibAccess, Myeloma17 September 2016
MPE encourages EMA to review its negative recommendation for ixazomibAccess, MPE, Myeloma16 August 2016
MPE to hold the “EHA 2016 Highlights in myeloma” webinar on 14th JulyConferences, MPE, Myeloma24 June 2016
MPE present at the XXXVI World Congress of the International Society of HematologyConferences, MPE19 April 2016
